Fundz

NEXGEL, INC. Announces Termination of CEO Adam R. Levy

PUBLIC · NXGLAug 21, 2026

Position

Chief Executive Officer

Company

NEXGEL

Adam R. Levy
LanghorneBiotechnologyHealth Care

Description

On August 21, 2026, NEXGEL, INC. terminated Adam R. Levy's employment as Chief Executive Officer without cause

Quick answer

NEXGEL, INC. Announces Termination of CEO Adam R. Levy (August 21, 2026). NEXGEL is based in Langhorne, Pennsylvania, United States.

What did NEXGEL announce on August 21, 2026?
On August 21, 2026, NEXGEL, INC. terminated Adam R. Levy's employment as Chief Executive Officer without cause
What does NEXGEL do?
Nexgel is a company focused on developing and commercializing innovative hydrogel products.
Where is NEXGEL based?
NEXGEL is based in Langhorne, Pennsylvania, United States.
Which similar companies made leadership changes around the same time?
DarioHealth (August 21, 2026), SPARSH Group of Hospitals (August 22, 2026), Nurix Therapeutics (August 21, 2026) and LivaNova (August 20, 2026) also announced leadership changes within 45 days of NEXGEL.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at NEXGEL, and when

A new leader at NEXGEL brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day NEXGEL raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NEXGEL, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NEXGEL. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NEXGEL

Location

2150 CABOT BOULEVARD WEST

Langhorne, Pennsylvania, United States

About

Nexgel is a company focused on developing and commercializing innovative hydrogel products. They specialize in regenerative biomaterials and have a range of products in various stages of development. The company aims to enhance patient care with their advanced biomaterial solutions. Nexgel is publicly traded under the ticker symbol NXGL.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NEXGEL changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Adam
Senior decision-maker at this company
••••••••@••••••••

See Adam's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NEXGEL's next move

Learn about Strategic plan

NEXGEL changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.